Target intelligence / Profile preview

Messenger RNA complementary to SA1 siRNA antisense strand

Molecular classification
Other (Messenger RNA)
01

Overview

The phrase "Messenger RNA complementary to SA1 siRNA antisense strand" describes the specific mRNA sequence targeted by the antisense strand of the SA1 siRNA molecule. In RNA interference (RNAi), siRNA molecules are designed so their antisense strand pairs exactly with the target mRNA; on binding, this recruits the RNA-induced silencing complex (RISC), ultimately leading to mRNA cleavage and gene silencing. Such design is widely used in experimental and therapeutic settings to knock down expression of specific genes. However, mRNA sequences themselves are not canonical molecular targets—these designations should refer to the actual gene or protein encoded by the mRNA, not to the descriptive relationship between the mRNA and the siRNA[1][3][4]. If you need structured target data, it is advisable to replace "Messenger RNA complementary to SA1 siRNA antisense strand" with the actual gene or protein name that is being silenced or knocked down in the experiment.

02

Mechanism of action

Cleavage and degradation of complementary mRNA by the RNA-induced silencing complex (RISC) when loaded with the antisense strand of siRNA

03

Biological functions

Encodes protein (if the mRNA is from a coding gene)Subject to RNA interference-mediated degradation
04

Disease associations

Other (depends entirely on what gene/protein the mRNA is encoding; the phrase itself does not specify a disease association)
05

Safety considerations

Off-target effects if the siRNA is not perfectly specificPotential for transient silencing due to lower stability of antisense RNA oligosRisk of unintended immune response to dsRNA/siRNA delivery
06

Interacting drugs

Short interfering RNA (siRNA) designed to target the sequence in question

Beyond the preview

Go deeper on Messenger RNA complementary to SA1 siRNA antisense strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Messenger RNA complementary to SA1 siRNA antisense strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call